These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20208358)

  • 1. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects.
    Hayashi N; Iida T; Yamada T; Okuma K; Takehara I; Yamamoto T; Yamada K; Tokuda M
    Biosci Biotechnol Biochem; 2010; 74(3):510-9. PubMed ID: 20208358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL/6J db/db mice.
    Baek SH; Park SJ; Lee HG
    J Food Sci; 2010 Mar; 75(2):H49-53. PubMed ID: 20492234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults.
    Iida T; Kishimoto Y; Yoshikawa Y; Hayashi N; Okuma K; Tohi M; Yagi K; Matsuo T; Izumori K
    J Nutr Sci Vitaminol (Tokyo); 2008 Dec; 54(6):511-4. PubMed ID: 19155592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.
    Braunstein CR; Noronha JC; Glenn AJ; Viguiliouk E; Noseworthy R; Khan TA; Au-Yeung F; Blanco Mejia S; Wolever TMS; Josse RG; Kendall CWC; Sievenpiper JL
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of xylose consumption on postprandial hyperglycemia in Korean: a randomized double-blind, crossover design.
    Jun YJ; Lee J; Hwang S; Kwak JH; Ahn HY; Bak YK; Koh J; Lee JH
    Trials; 2016 Mar; 17(1):139. PubMed ID: 26979433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.
    Fineman M; Weyer C; Maggs DG; Strobel S; Kolterman OG
    Horm Metab Res; 2002 Sep; 34(9):504-8. PubMed ID: 12384827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH; Wudy A; Eberlein G; Quast C
    Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women.
    Melanson KJ; Zukley L; Lowndes J; Nguyen V; Angelopoulos TJ; Rippe JM
    Nutrition; 2007 Feb; 23(2):103-12. PubMed ID: 17234503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Hossain MA; Kitagaki S; Nakano D; Nishiyama A; Funamoto Y; Matsunaga T; Tsukamoto I; Yamaguchi F; Kamitori K; Dong Y; Hirata Y; Murao K; Toyoda Y; Tokuda M
    Biochem Biophys Res Commun; 2011 Feb; 405(1):7-12. PubMed ID: 21187061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In children using intensive insulin therapy, a 20-g variation in carbohydrate amount significantly impacts on postprandial glycaemia.
    Smart CE; King BR; McElduff P; Collins CE
    Diabet Med; 2012 Jul; 29(7):e21-4. PubMed ID: 22268422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.
    Malone JK; Yang H; Woodworth JR; Huang J; Campaigne BN; Halle JP; Yale JF; Grossman LD
    Diabetes Metab; 2000 Dec; 26(6):481-7. PubMed ID: 11173719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
    Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M
    Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic health benefits of D-psicose.
    Chung MY; Oh DK; Lee KW
    J Agric Food Chem; 2012 Feb; 60(4):863-9. PubMed ID: 22224918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.